Michael Nedelcovych
Stock Analyst at TD Cowen
(1.09)
# 3,842
Out of 5,014 analysts
93
Total ratings
47.1%
Success rate
-1.8%
Average return
Main Sectors:
Stocks Rated by Michael Nedelcovych
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4568 Daiichi Sankyo Company, Limited | Reiterated: Buy | ¥6,550 → ¥3,590 | ¥2,754 | +30.38% | 2 | Sep 28, 2026 | |
| NVO Novo Nordisk | Reiterated: Hold | $42 | $37.91 | +10.79% | 32 | Sep 22, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $250 → $300 | $264.74 | +13.32% | 3 | Sep 14, 2026 | |
| RPRX Royalty Pharma | Rated: Buy | $65 → $68 | $58.36 | +16.52% | 11 | Sep 8, 2026 | |
| TSX: APTX Apotex Health Corp. | Initiated Coverage: Buy | $40.00 | $31.13 | +28.49% | 1 | Jul 6, 2026 | |
| TAK Takeda Pharmaceutical Company | Reiterated: Buy | $21 | $18.19 | +15.45% | 14 | Jun 4, 2026 | |
| CHRS Coherus Oncology | Reiterated: Buy | n/a | $1.21 | - | 13 | May 28, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Reiterated: Hold | $9.90 | $8.29 | +19.48% | 9 | Apr 30, 2026 | |
| SWX: MOLN Molecular Partners AG | Reiterated: Buy | CHF 15.00 | CHF 3.32 | +351.81% | 6 | Mar 16, 2026 | |
| TYO: 4502 Takeda Pharmaceutical Company Limited | Reiterated: Buy | ¥5,135 | ¥5,707 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $3.91 | n/a | 1 | Mar 14, 2025 |
Daiichi Sankyo Company, Limited
Sep 28, 2026
Reiterated: Buy
Price Target: ¥6,550 → ¥3,590
Current: ¥2,754
Upside: +30.38%
Novo Nordisk
Sep 22, 2026
Reiterated: Hold
Price Target: $42
Current: $37.91
Upside: +10.79%
Johnson & Johnson
Sep 14, 2026
Reiterated: Buy
Price Target: $250 → $300
Current: $264.74
Upside: +13.32%
Royalty Pharma
Sep 8, 2026
Rated: Buy
Price Target: $65 → $68
Current: $58.36
Upside: +16.52%
Apotex Health Corp.
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $40.00
Current: $31.13
Upside: +28.49%
Takeda Pharmaceutical Company
Jun 4, 2026
Reiterated: Buy
Price Target: $21
Current: $18.19
Upside: +15.45%
Coherus Oncology
May 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.21
Upside: -
Bausch Health Companies Inc.
Apr 30, 2026
Reiterated: Hold
Price Target: $9.90
Current: $8.29
Upside: +19.48%
Molecular Partners AG
Mar 16, 2026
Reiterated: Buy
Price Target: CHF 15.00
Current: CHF 3.32
Upside: +351.81%
Takeda Pharmaceutical Company Limited
May 21, 2025
Reiterated: Buy
Price Target: ¥5,135
Current: ¥5,707
Upside: n/a
Mar 14, 2025
Reiterated: Buy
Price Target: $17
Current: $3.91
Upside: n/a